IL17A and inflammatory bowel disease: However, blockade of IL-12p40, which is required for biological activity of both IL-12 and IL-23 and hence is a common upstream signal for both IL-17A and IFN-γ production, shows therapeutic promise in IBD (Mannon et al., 2004).